Santhera Pharmaceuticals Investor Relations Material
Latest events
H2 2024
Santhera Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Santhera Pharmaceuticals Holding Ltd
Access all reports
Santhera Pharmaceuticals Holding Ltd is a biopharmaceutical company focused on developing treatments for neuromuscular and rare diseases. The company specializes in innovative therapies targeting genetic and mitochondrial disorders, aiming to address conditions with high unmet medical needs. Its research and development efforts include advancing novel drug candidates through clinical trials and regulatory approvals. The company is headquartered in Pratteln, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Santhera Pharmaceuticals Holding Ltd
H2 2024
Santhera Pharmaceuticals Holding Ltd
H2 2024
Santhera Pharmaceuticals Holding Ltd
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
SANN
Country
🇨🇭 Switzerland